Dr. McCollum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5900 Lake Wright Dr
Norfolk, VA 23502Phone+1 757-466-8683Fax+1 757-466-0250
Summary
- Dr. Michael McCollum is an Obstetrics and Gynecology specialist with a subspecialty in Gynecologic Oncology, based in Norfolk, VA. He completed his medical education at Virginia Commonwealth University School of Medicine and conducted his residencies at MedStar Health/Franklin Square and Johns Hopkins University. Known for his expertise in gynecologic oncology, Dr. McCollum has been involved in significant clinical research, with publications in prominent journals such as the Journal of Gynecologic Oncology and Journal of Clinical Oncology. His research often focuses on ovarian and endometrial cancers. He has participated in several clinical trials, including studies on advanced cancer treatments. Dr. McCollum's professional recognitions include being named a Regional Top Doctor by Castle Connolly and obtaining certification for meaningful use from CMS, alongside being a Fellow of the American Congress of Obstetricians and Gynecologists.
Education & Training
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1992 - 1994
MedStar Health Georgetown University/Washington Hospital Center (Baltimore)Residency, Obstetrics and Gynecology, 1988 - 1992
Virginia Commonwealth University School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 2008 - 2026
CT State Medical License 2002 - 2015
NJ State Medical License 1992 - 2015
MD State Medical License 1991 - 2009
GA State Medical License 1994 - 1995
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer Start of enrollment: 2013 Feb 01
- A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer Start of enrollment: 2020 Jul 15
Publications & Presentations
PubMed
- Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistan...Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz
Journal of Gynecologic Oncology. 2024-07-01 - 69 citationsDurvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase I...Shannon N Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin
Journal of Clinical Oncology. 2024-01-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
